Evidence map›Paper›PMID 20154088›Full record

ArticleThe Journal of biological chemistry2010

Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesis.

Navtej S Buttar, Cathrine J DeMars, Gwen Lomberk, Sumera I Ilyas, Juliana Bonilla-Velez, Shalini Achra, Shahrooz Rashtak, Kenneth K Wang, Martin E Fernandez-Zapico, Raul Urrutia

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. PrPStem cell reports · 2026
    Article
  3. Cells · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Differential coupling of KLF10 to Sin3-HDAC and PCAF regulates the inducibility of the FOXP3 gene.American journal of physiology. Regulatory, integrative and comparative physiology · 2014
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Navtej S ButtarDivision of Gastroenterology, Mayo Clinic, Rochester, Minnesota 55902, USA. buttar.navtej@mayo.edu
Cathrine J DeMars
Gwen Lomberk
Sumera I Ilyas
Juliana Bonilla-Velez
Shalini Achra
Shahrooz Rashtak
Kenneth K Wang
Martin E Fernandez-Zapico
Raul Urrutia
University of Minnesota Rochester · USMayo Clinic in Arizona · US

Funding

ZINC FINGER GENES AND PANCREATIC CELL GROWTHR01DK052913 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI LOMBERK, GWEN, URRUTIA, RAUL A. · 1998 to 2023
$7.0M
Mechanism of Pancreatic CarcinogenesisR01CA136526 · NCI · MAYO CLINIC ROCHESTER · PI FERNANDEZ-ZAPICO, MARTIN ERNESTO · 2009 to 2019
$3.0M
Growth Regulatory Mechanisms of KLF in Barrett's EpitheliumK08DK076845 · NIDDK · MAYO CLINIC ROCHESTER · PI BUTTAR, NAVTEJ S · 2007 to 2011
$686k
The Role of Zinc Finger Genes in Pancreatic Cell GrowthR56DK052913 · NIDDK · MAYO CLINIC ROCHESTER · PI URRUTIA, RAUL A. · 2008 to 2008
$291k
Combinational Chemoprevention of Esophageal Adenocarcin*R03CA110022 · NCI · MAYO CLINIC · PI BUTTAR, NAVTEJ S · 2004 to 2005
$148k
Hedgehog-mediated survival mechanisms in pancreatic cancerR03CA125127 · NCI · MAYO CLINIC ROCHESTER · PI FERNANDEZ-ZAPICO, MARTIN ERNESTO · 2006 to 2007
$146k
NCI NIH HHS CA110022-01NCI NIH HHS CA125127NCI NIH HHS CA136526NCI NIH HHS R01 CA136526NCI NIH HHS R03 CA110022NCI NIH HHS R03 CA125127NIDDK NIH HHS DK076845-01NIDDK NIH HHS DK52913NIDDK NIH HHS K08 DK076845NIDDK NIH HHS R01 DK052913NIDDK NIH HHS R56 DK052913
6 · The paper itself

Abstract

Kruppel-like factor (KLF) proteins are emerging as key regulators of lipid metabolism, diabetes, and the biosynthesis of immunological cytokines. However, their role in the synthesis of prostaglandins, widely known biochemical mediators that act in a myriad of cell biological processes remain poorly understood. Consequently, in this study a comprehensive investigation at the cellular, biochemical, and molecular levels reveal that KLF11 inhibits prostaglandin E(2) synthesis via transcriptional silencing of the promoter of its biosynthetic enzyme, cytosolic phospholipase A2alpha. Mechanistically, KLF11 accomplishes this function by binding to the promoter via specific GC-rich sites and recruiting the Sin3-histone deacetylase chromatin remodeling complex. Further functional characterization reveals that this function of KLF11 can be reversed by epidermal growth factor receptor-AKT-mediated post-translational modification of threonine 56, a residue within its Sin3-binding domain. This is the first evidence supporting a relevant role for any KLF protein in doing both: transcriptionally inhibiting prostaglandin biosynthesis and its reversibility by an epidermal growth factor receptor-AKT signaling-mediated posttranslational mechanisms.

Indexed as

AnimalsApoptosis Regulatory ProteinsCell Cycle ProteinsCell LineCell ProliferationCHO CellsChromatinCricetinaeCricetulusDinoprostoneEpigenesis, GeneticHumansLipidsModels, BiologicalModels, GeneticPhospholipases A2Apoptosis Regulatory ProteinsCell Cycle ProteinsChromatinDinoprostoneKLF11 protein, humanLipidsPhospholipases A2Repressor Proteins

Identifiers

PMID20154088
PMCPMC2857022
OpenAlexW2067407021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.